DRUG-CLASS OVERVIEW:@0.982174:0.513429:0.982174:0.311367:0.954164:0.311367:0.954164:0.513429:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.233372:0.041064:0.000000:0.000000:0.019473
193:@0.945393:0.038601:0.984904:0.038601:0.984904:0.019004:0.945393:0.019004:0.013170:0.013170:0.013170
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
9. MOTOR INHIBITORS:@0.084848:0.079411:0.324267:0.079411:0.324267:0.059814:0.084848:0.059814:0.013170:0.006585:0.006585:0.021167:0.019756:0.009878:0.019756:0.013641:0.006585:0.006585:0.017404:0.015993:0.006585:0.013641:0.006585:0.009878:0.019756:0.013641:0.012230
The mammalian target for rapamycin :@0.084848:0.097138:0.481086:0.097138:0.481086:0.081382:0.084848:0.081382:0.008197:0.011738:0.012508:0.015490:0.018049:0.013143:0.018049:0.018049:0.013143:0.003848:0.003848:0.013154:0.011738:0.015490:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.015490:0.006042:0.012604:0.005782:0.015490:0.005792:0.013143:0.013123:0.013143:0.018049:0.010314:0.012450:0.003848:0.011738:0.005330
(mTOR)  is a  mediator  of  tumour  progres-:@0.084848:0.112576:0.475769:0.112576:0.475769:0.096820:0.084848:0.096820:0.007100:0.018049:0.008197:0.016722:0.011680:0.007100:0.005330:0.003088:0.003848:0.007466:0.008428:0.013143:0.005330:0.003086:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012604:0.005792:0.005330:0.003083:0.012604:0.006042:0.005330:0.003081:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.003077:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.006388
sion and forms part of the PI3K/AKT/mTOR :@0.084848:0.128015:0.481094:0.128015:0.481094:0.112259:0.084848:0.112259:0.007466:0.003848:0.012604:0.011738:0.005946:0.013143:0.011738:0.013181:0.005946:0.006042:0.012604:0.006317:0.018049:0.007466:0.005946:0.013123:0.013143:0.005792:0.006523:0.005946:0.012604:0.006042:0.005946:0.006523:0.011738:0.012508:0.005946:0.011392:0.004349:0.010660:0.011372:0.008409:0.014239:0.011372:0.008197:0.008409:0.018049:0.008197:0.016722:0.011680:0.005330
pathway.  Activation of the mTOR kinase :@0.084848:0.143453:0.481094:0.143440:0.481094:0.127684:0.084848:0.127697:0.013123:0.013143:0.006523:0.011738:0.015990:0.013143:0.010314:0.005330:0.012437:0.006235:0.014239:0.012450:0.006523:0.003848:0.010660:0.013143:0.006523:0.003848:0.012604:0.011738:0.006235:0.012604:0.006042:0.006235:0.006523:0.011738:0.012508:0.006235:0.018049:0.008197:0.016722:0.011680:0.006235:0.009660:0.003848:0.011738:0.013143:0.007466:0.012508:0.793058
52:@0.174154:0.137821:0.186584:0.137821:0.186584:0.128635:0.174154:0.128635:0.006215:0.006215
activity by phosphorylation results in the :@0.084854:0.158878:0.481111:0.158878:0.481111:0.143123:0.084854:0.143123:0.013143:0.012450:0.006523:0.003848:0.010660:0.003848:0.006523:0.010314:0.009679:0.013123:0.010314:0.009679:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.012604:0.005792:0.010314:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.009679:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.009679:0.003848:0.011738:0.009679:0.006523:0.011738:0.012508:0.005330
interpretation of a variety of growth and :@0.084854:0.174317:0.481096:0.174317:0.481096:0.158561:0.084854:0.158561:0.003848:0.011738:0.006523:0.012508:0.005792:0.013123:0.005707:0.012508:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007993:0.012604:0.006042:0.007995:0.013143:0.008005:0.010660:0.013143:0.005792:0.003848:0.012508:0.006523:0.010314:0.008005:0.012604:0.006042:0.007995:0.012950:0.005709:0.012604:0.015990:0.006523:0.011738:0.007993:0.013143:0.011738:0.013181:0.005330
survival  signals received by the cancer :@0.084854:0.189755:0.481084:0.189755:0.481084:0.173999:0.084854:0.173999:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330:0.006215:0.007466:0.003848:0.012950:0.011738:0.013143:0.003848:0.007478:0.011526:0.005713:0.012508:0.012450:0.012508:0.003848:0.010660:0.012508:0.013181:0.011526:0.013123:0.010314:0.011526:0.006523:0.011738:0.012508:0.011526:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
cells and the upregulation  of  proteins :@0.084854:0.205194:0.481111:0.205194:0.481111:0.189438:0.084854:0.189438:0.012450:0.012508:0.003848:0.003848:0.007466:0.014085:0.013143:0.011738:0.013181:0.014085:0.006523:0.011738:0.012508:0.014085:0.011699:0.013123:0.005713:0.012508:0.012950:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.008746:0.012604:0.006042:0.005330:0.008744:0.013123:0.005717:0.012604:0.006523:0.012508:0.003848:0.011738:0.007466:0.005330
needed for the cell’s survival.:@0.084854:0.220632:0.356326:0.220632:0.356326:0.204876:0.084854:0.204876:0.011738:0.012508:0.012508:0.013181:0.012508:0.013181:0.005330:0.006042:0.012604:0.005792:0.005330:0.006523:0.011738:0.012508:0.005330:0.012450:0.012508:0.003848:0.003848:0.006754:0.007466:0.005330:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330
26,52:@0.356309:0.214991:0.384276:0.214991:0.384276:0.205806:0.356309:0.205806:0.006215:0.006215:0.003107:0.006215:0.006215
 :@0.384283:0.220610:0.389614:0.220610:0.389614:0.204854:0.384283:0.204854:0.005330
Everolimus and temsirolimus are inhibi-:@0.103036:0.236049:0.475745:0.236049:0.475745:0.220293:0.103036:0.220293:0.010314:0.010660:0.012508:0.005717:0.012604:0.003848:0.003848:0.018049:0.011699:0.007466:0.010102:0.013143:0.011738:0.013181:0.010102:0.006523:0.012508:0.018049:0.007466:0.003848:0.005715:0.012604:0.003848:0.003848:0.018049:0.011699:0.007466:0.010102:0.013143:0.005715:0.012508:0.010102:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006388
tors of mTOR.:@0.084852:0.251487:0.220838:0.251487:0.220838:0.235731:0.084852:0.235731:0.006523:0.012604:0.005792:0.007466:0.012488:0.012604:0.006042:0.012488:0.018049:0.008197:0.016722:0.011680:0.005330
26,52:@0.220816:0.245859:0.248784:0.245859:0.248784:0.236674:0.220816:0.236674:0.006215:0.006215:0.003107:0.006215:0.006215
 These agents prevent :@0.248791:0.251478:0.481104:0.251478:0.481104:0.235722:0.248791:0.235722:0.012488:0.008197:0.011738:0.012508:0.007466:0.012508:0.012488:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.012488:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.005330
mTOR-mediated phosphorylation of key :@0.084845:0.266917:0.481104:0.266917:0.481104:0.251161:0.084845:0.251161:0.018049:0.008197:0.016722:0.011680:0.006388:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.013181:0.011873:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.012604:0.005792:0.010314:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.011873:0.012604:0.006042:0.011873:0.009660:0.012508:0.010314:0.005330
kinases by binding with high affinity to the :@0.084845:0.282355:0.481091:0.282355:0.481091:0.266599:0.084845:0.266599:0.009660:0.003848:0.011738:0.013143:0.007466:0.012508:0.007466:0.006004:0.013123:0.010314:0.006000:0.013123:0.003848:0.011738:0.013181:0.003848:0.011738:0.012950:0.006000:0.015990:0.003848:0.006523:0.011738:0.005996:0.011738:0.003848:0.012950:0.011738:0.005990:0.013143:0.006042:0.004686:0.004686:0.011738:0.003848:0.006523:0.010314:0.005996:0.006523:0.012604:0.005988:0.006523:0.011738:0.012508:0.005330
intracellular receptor FKBP12.:@0.084845:0.297794:0.354339:0.297794:0.354339:0.282038:0.084845:0.282038:0.003848:0.011738:0.006523:0.005792:0.013143:0.012450:0.012508:0.003848:0.003848:0.011699:0.003848:0.013143:0.005792:0.005157:0.005713:0.012508:0.012450:0.012508:0.013123:0.006523:0.012604:0.005792:0.005143:0.009333:0.011372:0.011045:0.011392:0.010660:0.010660:0.005330
26,52:@0.354344:0.292161:0.382311:0.292161:0.382311:0.282976:0.354344:0.282976:0.006215:0.006215:0.003107:0.006215:0.006215
 The inhib-:@0.382318:0.297780:0.475759:0.297780:0.475759:0.282024:0.382318:0.282024:0.005157:0.008197:0.011738:0.012508:0.005157:0.003848:0.011738:0.011738:0.003848:0.013123:0.006388
itor-FKBP12 complex binds to  mTOR and :@0.084850:0.313219:0.481099:0.313219:0.481099:0.297463:0.084850:0.297463:0.003848:0.006523:0.012604:0.005792:0.006388:0.009333:0.011372:0.011045:0.011392:0.010660:0.010660:0.009660:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.009236:0.009660:0.013123:0.003848:0.011738:0.013181:0.007466:0.009660:0.006523:0.012604:0.005330:0.004320:0.018049:0.008197:0.016722:0.011680:0.009660:0.013143:0.011738:0.013181:0.005330
prevents downstream signalling.  The :@0.084850:0.328657:0.481101:0.328648:0.481101:0.312892:0.084850:0.312901:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.007466:0.019396:0.013181:0.012604:0.015990:0.011738:0.007466:0.006523:0.005709:0.012508:0.013143:0.018049:0.019396:0.007466:0.003848:0.012950:0.011738:0.013143:0.003848:0.003848:0.003848:0.011738:0.012950:0.005330:0.012428:0.019396:0.008197:0.011738:0.012508:0.523658
52:@0.411497:0.323029:0.423927:0.323029:0.423927:0.313844:0.411497:0.313844:0.006215:0.006215
cancer cell’s cell cycle is arrested at the :@0.084842:0.344087:0.481107:0.344087:0.481107:0.328331:0.084842:0.328331:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007583:0.012450:0.012508:0.003848:0.003848:0.006754:0.007466:0.007601:0.012450:0.012508:0.003848:0.003848:0.007601:0.012450:0.010314:0.012450:0.003848:0.012508:0.007601:0.003848:0.007466:0.007601:0.013143:0.005792:0.005711:0.012508:0.007466:0.006523:0.012508:0.013181:0.007589:0.013143:0.006523:0.007601:0.006523:0.011738:0.012508:0.005330
G -phase and angiogenesis is inhibited.  :@0.084842:0.359525:0.471199:0.359516:0.471199:0.343760:0.084842:0.343769:0.016779:0.008297:0.006388:0.013123:0.011738:0.013143:0.007466:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.013143:0.011738:0.012950:0.003848:0.012604:0.012950:0.012508:0.011738:0.012508:0.007466:0.003848:0.007466:0.005330:0.003848:0.007466:0.005330:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012508:0.013181:0.005330:0.012435:0.488660
1:@0.101629:0.363272:0.109916:0.363272:0.109916:0.351025:0.101629:0.351025:0.008287
52:@0.453435:0.353897:0.465865:0.353897:0.465865:0.344712:0.453435:0.344712:0.006215:0.006215
Everolimus and temsirolimus are indicat-:@0.103035:0.374955:0.475762:0.374955:0.475762:0.359199:0.103035:0.359199:0.010314:0.010660:0.012508:0.005717:0.012604:0.003848:0.003848:0.018049:0.011699:0.007466:0.005965:0.013143:0.011738:0.013181:0.005956:0.006523:0.012508:0.018049:0.007466:0.003848:0.005715:0.012604:0.003848:0.003848:0.018049:0.011699:0.007466:0.005965:0.013143:0.005715:0.012508:0.005956:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.006388
ed for  palliative monotherapy treatment :@0.084850:0.390393:0.481098:0.390393:0.481098:0.374637:0.084850:0.374637:0.012508:0.013181:0.008736:0.006042:0.012604:0.005792:0.005330:0.003396:0.013123:0.013143:0.003848:0.003848:0.003848:0.013143:0.006523:0.003848:0.010681:0.012508:0.008736:0.018049:0.012604:0.011738:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013106:0.010314:0.008736:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
of advanced renal cell cancer.  :@0.084850:0.405832:0.394171:0.405818:0.394171:0.390063:0.084850:0.390076:0.012604:0.006042:0.005330:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330:0.005707:0.012508:0.011738:0.013143:0.003848:0.005330:0.012450:0.012508:0.003848:0.003848:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330:0.012430:0.498340
13:@0.376406:0.400199:0.388836:0.400199:0.388836:0.391014:0.376406:0.391014:0.006215:0.006215
Side effects:@0.084848:0.433194:0.204835:0.433194:0.204835:0.415687:0.084848:0.415687:0.010647:0.004276:0.014646:0.013897:0.005922:0.013897:0.006713:0.006713:0.013897:0.013833:0.007248:0.008296
13:@0.204832:0.426951:0.218642:0.426951:0.218642:0.416744:0.204832:0.416744:0.006905:0.006905
n :@0.084848:0.448713:0.098177:0.448713:0.098177:0.440273:0.084848:0.440273:0.009762:0.003566
 :@0.115149:0.448713:0.118715:0.448713:0.118715:0.440273:0.115149:0.440273:0.003566
Infections:@0.115151:0.451832:0.204417:0.451832:0.204417:0.436076:0.115151:0.436076:0.004349:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466
n :@0.084848:0.464735:0.098177:0.464735:0.098177:0.456295:0.084848:0.456295:0.009762:0.003566
 :@0.115149:0.464735:0.118715:0.464735:0.118715:0.456295:0.115149:0.456295:0.003566
Rhinitis :@0.115151:0.467854:0.181172:0.467854:0.181172:0.452098:0.115151:0.452098:0.011680:0.011738:0.003848:0.011738:0.003848:0.006523:0.003848:0.007466:0.005330
n :@0.084848:0.480757:0.098177:0.480757:0.098177:0.472317:0.084848:0.472317:0.009762:0.003566
 :@0.115149:0.480757:0.118715:0.480757:0.118715:0.472317:0.115149:0.472317:0.003566
Folliculitis :@0.115151:0.483876:0.203647:0.483876:0.203647:0.468120:0.115151:0.468120:0.009333:0.012604:0.003848:0.003848:0.003848:0.012450:0.011699:0.003848:0.003848:0.006523:0.003848:0.007466:0.005330
n :@0.084848:0.496779:0.098177:0.496779:0.098177:0.488339:0.084848:0.488339:0.009762:0.003566
 :@0.115149:0.496779:0.118715:0.496779:0.118715:0.488339:0.115149:0.488339:0.003566
Pneumonia :@0.115151:0.499898:0.227200:0.499898:0.227200:0.484142:0.115151:0.484142:0.011392:0.011738:0.012508:0.011699:0.018049:0.012604:0.011738:0.003848:0.013143:0.005330
n :@0.084848:0.512801:0.098177:0.512801:0.098177:0.504361:0.084848:0.504361:0.009762:0.003566
 :@0.115149:0.512801:0.118715:0.512801:0.118715:0.504361:0.115149:0.504361:0.003566
Anaemia, thrombocytopaenia :@0.115151:0.515920:0.407557:0.515920:0.407557:0.500164:0.115151:0.500164:0.014239:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330:0.006523:0.011738:0.005713:0.012604:0.018049:0.013123:0.012604:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330
n :@0.084848:0.528823:0.098177:0.528823:0.098177:0.520383:0.084848:0.520383:0.009762:0.003566
 :@0.115149:0.528823:0.118715:0.528823:0.118715:0.520383:0.115149:0.520383:0.003566
Neutropaenia, leukopaenia, :@0.115151:0.531942:0.385078:0.531942:0.385078:0.516186:0.115151:0.516186:0.014239:0.012508:0.011699:0.006523:0.005709:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.005330:0.003848:0.012508:0.011699:0.009660:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.005330
lymphopaenia:@0.115151:0.547381:0.252331:0.547381:0.252331:0.531625:0.115151:0.531625:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143
n :@0.084848:0.560279:0.098177:0.560279:0.098177:0.551839:0.084848:0.551839:0.009762:0.003566
 :@0.115149:0.560279:0.118715:0.560279:0.118715:0.551839:0.115149:0.551839:0.003566
Allergic reactions :@0.115151:0.563398:0.281302:0.563398:0.281302:0.547642:0.115151:0.547642:0.014239:0.003848:0.003848:0.012508:0.005807:0.012950:0.003848:0.012450:0.005330:0.005711:0.012508:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
n :@0.084848:0.576301:0.098177:0.576301:0.098177:0.567861:0.084848:0.567861:0.009762:0.003566
 :@0.115149:0.576301:0.118715:0.576301:0.118715:0.567861:0.115149:0.567861:0.003566
Dyspnoea, cough, epistaxis   :@0.115151:0.579420:0.398055:0.579420:0.398055:0.563664:0.115151:0.563664:0.014316:0.010314:0.007466:0.013123:0.011738:0.012604:0.012508:0.013143:0.005330:0.005330:0.012436:0.012604:0.011699:0.012950:0.011738:0.005330:0.005330:0.012508:0.013123:0.003848:0.007466:0.006523:0.013143:0.009236:0.003848:0.007466:0.005330:0.017122:0.005330
n :@0.084848:0.592323:0.098177:0.592323:0.098177:0.583883:0.084848:0.583883:0.009762:0.003566
 :@0.115149:0.592323:0.118715:0.592323:0.118715:0.583883:0.115149:0.583883:0.003566
Anorexia :@0.115151:0.595442:0.203511:0.595442:0.203511:0.579686:0.115151:0.579686:0.014239:0.011738:0.012604:0.005713:0.012508:0.009236:0.003848:0.013143:0.005330
n :@0.084848:0.608345:0.098177:0.608345:0.098177:0.599905:0.084848:0.599905:0.009762:0.003566
 :@0.115149:0.608345:0.118715:0.608345:0.118715:0.599905:0.115149:0.599905:0.003566
Hyperlipidaemia, hyperglycaemia, :@0.115151:0.611464:0.443631:0.611464:0.443631:0.595708:0.115151:0.595708:0.013143:0.010314:0.013123:0.012508:0.005792:0.003848:0.003848:0.013123:0.003848:0.013181:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330:0.011738:0.010314:0.013123:0.012508:0.005804:0.012950:0.003848:0.010314:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330
hypercholesterolaemia :@0.115151:0.626903:0.336314:0.626903:0.336314:0.611147:0.115151:0.611147:0.011738:0.010314:0.013123:0.012508:0.005657:0.012450:0.011738:0.012604:0.003848:0.012508:0.007466:0.006523:0.012508:0.005705:0.012604:0.003848:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330
n :@0.084848:0.639801:0.098177:0.639801:0.098177:0.631361:0.084848:0.631361:0.009762:0.003566
 :@0.115149:0.639801:0.118715:0.639801:0.118715:0.631361:0.115149:0.631361:0.003566
Hypokalaemia, hypophosphataemia :@0.115151:0.642920:0.465594:0.642920:0.465594:0.627164:0.115151:0.627164:0.013143:0.010314:0.013123:0.012604:0.009660:0.013143:0.003848:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330:0.011738:0.010314:0.013123:0.012604:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.013143:0.006523:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330
n :@0.084848:0.655823:0.098177:0.655823:0.098177:0.647383:0.084848:0.647383:0.009762:0.003566
 :@0.115149:0.655823:0.118715:0.655823:0.118715:0.647383:0.115149:0.647383:0.003566
Dysgeusia :@0.115151:0.658942:0.214192:0.658942:0.214192:0.643186:0.115151:0.643186:0.014316:0.010314:0.007466:0.012950:0.012508:0.011699:0.007466:0.003848:0.013143:0.005330
n :@0.084848:0.671845:0.098177:0.671845:0.098177:0.663405:0.084848:0.663405:0.009762:0.003566
 :@0.115149:0.671845:0.118715:0.671845:0.118715:0.663405:0.115149:0.663405:0.003566
Conjunctivitis :@0.115151:0.674964:0.242979:0.674964:0.242979:0.659208:0.115151:0.659208:0.015644:0.012604:0.011738:0.003906:0.011699:0.011738:0.012450:0.006523:0.003848:0.010660:0.003848:0.006523:0.003848:0.007466:0.005330
n :@0.084848:0.687867:0.098177:0.687867:0.098177:0.679427:0.084848:0.679427:0.009762:0.003566
 :@0.115149:0.687867:0.118715:0.687867:0.118715:0.679427:0.115149:0.679427:0.003566
Hypertension, venous :@0.115151:0.690986:0.319111:0.690986:0.319111:0.675230:0.115151:0.675230:0.013143:0.010314:0.013123:0.012508:0.005792:0.006523:0.012508:0.011738:0.007466:0.003848:0.012594:0.011738:0.005330:0.005330:0.010660:0.012508:0.011738:0.012604:0.011699:0.007466:0.005330
thrombo-embolism:@0.115151:0.706425:0.291385:0.706425:0.291385:0.690669:0.115151:0.690669:0.006523:0.011738:0.005707:0.012604:0.018049:0.013123:0.012604:0.006388:0.012508:0.018049:0.013123:0.012604:0.003848:0.003848:0.007466:0.018049
Contra-indications, special  precautions :@0.103029:0.721863:0.481096:0.721863:0.481096:0.706107:0.103029:0.706107:0.015644:0.012604:0.011738:0.006523:0.005792:0.013143:0.006388:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.008986:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.005330:0.003670:0.013123:0.005713:0.012508:0.012450:0.013143:0.011699:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
and drug interactions: See :@0.084845:0.737302:0.339191:0.737302:0.339191:0.721546:0.084845:0.721546:0.013143:0.011738:0.013181:0.006408:0.013181:0.005792:0.011699:0.012950:0.006408:0.003848:0.011738:0.006523:0.012508:0.005792:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.006408:0.009583:0.012508:0.012508:0.005330
MIMS Monthly, :@0.340268:0.737302:0.481084:0.737302:0.481084:0.721546:0.340268:0.721546:0.017684:0.004349:0.017684:0.009583:0.006408:0.017684:0.012604:0.011738:0.006523:0.011738:0.003848:0.010314:0.005330:0.005330
MDR:@0.084845:0.752740:0.128525:0.752740:0.128525:0.736984:0.084845:0.736984:0.017684:0.014316:0.011680
 or manufacturer’s product literature.:@0.128525:0.752740:0.473653:0.752740:0.473653:0.736984:0.128525:0.736984:0.005330:0.012604:0.005792:0.005330:0.018049:0.013143:0.011738:0.011699:0.006042:0.013143:0.012450:0.006523:0.011699:0.005694:0.012508:0.005792:0.006754:0.007466:0.005330:0.013123:0.005711:0.012604:0.013181:0.011699:0.012450:0.006523:0.005330:0.003848:0.003848:0.006523:0.012508:0.005792:0.013143:0.006523:0.011699:0.005698:0.012508:0.005330
10. IMiDs:@0.524242:0.079411:0.623937:0.079411:0.623937:0.059814:0.524242:0.059814:0.013170:0.013170:0.006585:0.006585:0.006585:0.021143:0.005644:0.016463:0.010348
Thalidomide was developed in the first half :@0.524242:0.097138:0.920478:0.097138:0.920478:0.081382:0.524242:0.081382:0.008197:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.004297:0.015990:0.013143:0.007466:0.004301:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.012508:0.013181:0.004297:0.003848:0.011738:0.004295:0.006523:0.011738:0.012508:0.004285:0.004686:0.004686:0.005792:0.007466:0.006523:0.004287:0.011738:0.013143:0.003848:0.006042:0.005330
of the 1950s as a sedative and hypnotic :@0.524242:0.112576:0.920476:0.112576:0.920476:0.096820:0.524242:0.096820:0.012604:0.006042:0.008197:0.006523:0.011738:0.012508:0.008197:0.010660:0.010660:0.010660:0.010660:0.007466:0.008211:0.013143:0.007466:0.008197:0.013143:0.008197:0.007466:0.012508:0.013181:0.013143:0.006523:0.003848:0.010660:0.012508:0.008197:0.013143:0.011738:0.013181:0.008197:0.011738:0.010314:0.013123:0.011738:0.012604:0.006523:0.003848:0.012450:0.005330
anti-emetic drug to treat morning sickness :@0.524242:0.128015:0.920491:0.128015:0.920491:0.112259:0.524242:0.112259:0.013143:0.011738:0.006523:0.003848:0.006388:0.012508:0.018049:0.012508:0.006523:0.003848:0.012450:0.005311:0.013181:0.005792:0.011699:0.012950:0.005297:0.006523:0.012604:0.005297:0.006523:0.005711:0.012508:0.013143:0.006523:0.005301:0.018049:0.012604:0.006188:0.011738:0.003848:0.011738:0.012950:0.005311:0.007466:0.003848:0.012450:0.009660:0.011738:0.012508:0.007466:0.007466:0.005330
in the first trimester of gestation, but was :@0.524242:0.143453:0.920481:0.143453:0.920481:0.127697:0.524242:0.127697:0.003848:0.011738:0.008172:0.006523:0.011738:0.012508:0.008168:0.004686:0.004686:0.005792:0.007466:0.006523:0.008168:0.006523:0.005792:0.003848:0.018049:0.012508:0.007466:0.006523:0.012508:0.005792:0.008163:0.012604:0.006042:0.008166:0.012950:0.012508:0.007466:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.008161:0.013123:0.011699:0.006523:0.008170:0.015990:0.013143:0.007466:0.005330
removed from the market after discovery :@0.524242:0.158892:0.920478:0.158892:0.920478:0.143136:0.524242:0.143136:0.005713:0.012508:0.018049:0.012604:0.010660:0.012508:0.013181:0.006802:0.006042:0.005713:0.012604:0.018049:0.006802:0.006523:0.011738:0.012508:0.006798:0.018049:0.013143:0.005792:0.009660:0.012508:0.006523:0.006798:0.013143:0.006042:0.006523:0.012508:0.005792:0.006800:0.013181:0.003848:0.007466:0.012450:0.012604:0.010660:0.012508:0.005792:0.010314:0.005330
of  its teratogenic  effects.:@0.524242:0.174330:0.769636:0.174330:0.769636:0.158574:0.524242:0.158574:0.012604:0.006042:0.005330:0.004468:0.003848:0.006523:0.007466:0.009814:0.006523:0.012508:0.005792:0.013143:0.006523:0.012604:0.012950:0.012508:0.011738:0.003848:0.012450:0.005330:0.004460:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330
53,54:@0.769620:0.168689:0.797587:0.168689:0.797587:0.159503:0.769620:0.159503:0.006215:0.006215:0.003107:0.006215:0.006215
  Since  then, :@0.797595:0.174308:0.920494:0.174308:0.920494:0.158552:0.797595:0.158552:0.005330:0.004472:0.009583:0.003848:0.011738:0.012450:0.012508:0.005330:0.004474:0.006523:0.011738:0.012508:0.011738:0.005330:0.005330
findings  of  thalidomide’s  anti-angiogenic :@0.524237:0.189747:0.920482:0.189747:0.920482:0.173991:0.524237:0.173991:0.004686:0.004686:0.011738:0.013181:0.003848:0.011738:0.012950:0.007466:0.005330:0.003289:0.012604:0.006042:0.005330:0.003289:0.006523:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.006754:0.007466:0.005330:0.003300:0.013143:0.011738:0.006523:0.003848:0.006388:0.013143:0.011738:0.012950:0.003848:0.012604:0.012950:0.012508:0.011738:0.003848:0.012450:0.005330
properties have led to the investigation of  :@0.524237:0.205185:0.920473:0.205185:0.920473:0.189429:0.524237:0.189429:0.013123:0.005715:0.012604:0.013123:0.012508:0.005792:0.006523:0.003848:0.012508:0.007466:0.005696:0.011738:0.013143:0.010660:0.012508:0.005696:0.003848:0.012508:0.013181:0.005696:0.006523:0.012604:0.005696:0.006523:0.011738:0.012508:0.005696:0.003848:0.011738:0.010660:0.012508:0.007466:0.006523:0.003848:0.012950:0.013143:0.006523:0.003848:0.012604:0.011738:0.005696:0.012604:0.006042:0.000000:0.005330
thalidomide as an anticancer agent in  :@0.524237:0.220623:0.920459:0.220623:0.920459:0.204867:0.524237:0.204867:0.006523:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.011430:0.013143:0.007466:0.011430:0.013143:0.011738:0.011430:0.013143:0.011738:0.006523:0.003848:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.011430:0.013143:0.012950:0.012508:0.011738:0.006523:0.011430:0.003848:0.011738:0.000000:0.005330
patients with vascular tumours.:@0.524237:0.236062:0.845662:0.236062:0.845662:0.220306:0.524237:0.220306:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.017030:0.015990:0.003848:0.006523:0.011738:0.017030:0.010660:0.013143:0.007466:0.012450:0.011699:0.003848:0.013143:0.005792:0.017030:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330
53,54:@0.845669:0.230425:0.873636:0.230425:0.873636:0.221240:0.845669:0.221240:0.006215:0.006215:0.003107:0.006215:0.006215
 Al-:@0.873643:0.236044:0.915149:0.236044:0.915149:0.220288:0.873643:0.220288:0.017030:0.014239:0.003848:0.006388
though the precise mechanism of action is :@0.524240:0.251483:0.920476:0.251483:0.920476:0.235727:0.524240:0.235727:0.006523:0.011738:0.012604:0.011699:0.012950:0.011738:0.004322:0.006523:0.011738:0.012508:0.004333:0.013123:0.005715:0.012508:0.012450:0.003848:0.007466:0.012508:0.004349:0.018049:0.012508:0.012450:0.011738:0.013143:0.011738:0.003848:0.007466:0.018049:0.004339:0.012604:0.006042:0.004335:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.004333:0.003848:0.007466:0.005330
not understood, thalidomide as an anti-:@0.524240:0.266921:0.915138:0.266921:0.915138:0.251165:0.524240:0.251165:0.011738:0.012604:0.006523:0.009563:0.011699:0.011738:0.013181:0.012508:0.005792:0.007466:0.006523:0.012604:0.012604:0.013170:0.005330:0.009563:0.006523:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.009563:0.013143:0.007466:0.009563:0.013143:0.011738:0.009563:0.013143:0.011738:0.006523:0.003848:0.006388
angiogenic  agent  leads to  the  develop-:@0.524240:0.282359:0.915149:0.282359:0.915149:0.266604:0.524240:0.266604:0.013143:0.011738:0.012950:0.003848:0.012604:0.012950:0.012508:0.011738:0.003848:0.012450:0.005330:0.002948:0.013143:0.012950:0.012508:0.011738:0.006523:0.005330:0.002948:0.003848:0.012508:0.013143:0.013181:0.007466:0.008293:0.006523:0.012604:0.005330:0.002948:0.006523:0.011738:0.012508:0.005330:0.002952:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.006388
ment  of new immunomodulatory  agents :@0.524240:0.297798:0.920499:0.297798:0.920499:0.282042:0.524240:0.282042:0.018049:0.012508:0.011738:0.006523:0.005330:0.003454:0.012604:0.006042:0.008794:0.011738:0.012508:0.015990:0.008794:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.018049:0.012604:0.013181:0.011699:0.003848:0.013143:0.006523:0.012604:0.005792:0.010314:0.005330:0.003454:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330
(IMiDs),  with thalidomide as  the parent :@0.524240:0.313236:0.920474:0.313236:0.920474:0.297480:0.524240:0.297480:0.007100:0.004349:0.017684:0.003848:0.014316:0.007466:0.007100:0.005330:0.005330:0.006485:0.015990:0.003848:0.006523:0.011738:0.011796:0.006523:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.011796:0.013143:0.007466:0.005330:0.006477:0.006523:0.011738:0.012508:0.011796:0.013123:0.013143:0.005717:0.012508:0.011738:0.006523:0.005330
compound  with  possibly  fewer  side ef-:@0.524240:0.328675:0.915144:0.328675:0.915144:0.312919:0.524240:0.312919:0.012450:0.012604:0.018049:0.013123:0.012604:0.011699:0.011738:0.013181:0.005330:0.006816:0.015990:0.003848:0.006523:0.011738:0.005330:0.006821:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.010314:0.005330:0.006843:0.006042:0.012508:0.015990:0.012508:0.005792:0.005330:0.006820:0.007466:0.003848:0.013181:0.012508:0.012161:0.012508:0.006042:0.006388
fects.:@0.524240:0.344113:0.574559:0.344113:0.574559:0.328357:0.524240:0.328357:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330
53,54:@0.574556:0.338463:0.602523:0.338463:0.602523:0.329278:0.574556:0.329278:0.006215:0.006215:0.003107:0.006215:0.006215
 The use of thalidomide is restrict-:@0.602530:0.344082:0.915169:0.344082:0.915169:0.328326:0.602530:0.328326:0.006485:0.008197:0.011738:0.012508:0.006469:0.011699:0.007466:0.012508:0.006485:0.012604:0.006042:0.006473:0.006523:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.006485:0.003848:0.007466:0.006485:0.005711:0.012508:0.007466:0.006523:0.005792:0.003848:0.012450:0.006523:0.006388
ed to patients and/or doctors and phar-:@0.524233:0.359521:0.915164:0.359521:0.915164:0.343765:0.524233:0.343765:0.012508:0.013181:0.007918:0.006523:0.012604:0.007912:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007928:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.007911:0.013181:0.012604:0.012450:0.006523:0.012604:0.005778:0.007466:0.007928:0.013143:0.011738:0.013181:0.007928:0.013123:0.011738:0.013143:0.005792:0.006388
macists in the Pharmion Risk Management :@0.524233:0.374959:0.920484:0.374959:0.920484:0.359203:0.524233:0.359203:0.018049:0.013143:0.012450:0.003848:0.007466:0.006523:0.007466:0.004830:0.003848:0.011738:0.004830:0.006523:0.011738:0.012508:0.004830:0.011392:0.011738:0.013143:0.006323:0.018049:0.003848:0.012604:0.011738:0.004830:0.011680:0.003848:0.007466:0.009660:0.004830:0.017684:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330
Programme (PRMP) and indicated for use :@0.524233:0.390398:0.920492:0.390398:0.920492:0.374642:0.524233:0.374642:0.011392:0.005709:0.012604:0.012950:0.005792:0.013143:0.018049:0.018049:0.012508:0.005948:0.007100:0.011392:0.011680:0.017684:0.011392:0.007100:0.005965:0.013143:0.011738:0.013181:0.005965:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.005965:0.006042:0.012604:0.005792:0.005950:0.011699:0.007466:0.012508:0.005330
in multiple myeloma.:@0.524233:0.405836:0.717831:0.405836:0.717831:0.390080:0.524233:0.390080:0.003848:0.011738:0.005388:0.018049:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.005330:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.005330
 :@0.539819:0.405836:0.545207:0.405836:0.545207:0.389802:0.539819:0.389802:0.005388
13:@0.717840:0.400199:0.730270:0.400199:0.730270:0.391014:0.717840:0.391014:0.006215:0.006215
Lenalidomide is an analogue of thalido-:@0.542424:0.421253:0.915141:0.421253:0.915141:0.405497:0.542424:0.405497:0.008890:0.012508:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.018049:0.003848:0.013181:0.012508:0.005523:0.003848:0.007466:0.005534:0.013143:0.011738:0.005523:0.013143:0.011738:0.013143:0.003848:0.012604:0.012950:0.011699:0.012508:0.005523:0.012604:0.006042:0.005523:0.006523:0.011738:0.013143:0.003848:0.003848:0.013181:0.012604:0.006388
mide with immunomodulatory, antiangio-:@0.524240:0.436691:0.915165:0.436691:0.915165:0.420935:0.524240:0.420935:0.018049:0.003848:0.013181:0.012508:0.006754:0.015990:0.003848:0.006523:0.011738:0.006754:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.018049:0.012604:0.013181:0.011699:0.003848:0.013143:0.006523:0.012604:0.005792:0.010300:0.005330:0.006744:0.013143:0.011738:0.006523:0.003848:0.013143:0.011738:0.012950:0.003848:0.012604:0.006388
genic, and antineoplastic properties.  :@0.524240:0.452129:0.920481:0.452121:0.920481:0.436365:0.524240:0.436373:0.012950:0.012508:0.011738:0.003848:0.012450:0.005330:0.014778:0.013143:0.011738:0.013181:0.014778:0.013143:0.011738:0.006523:0.003848:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.014778:0.013123:0.005715:0.012604:0.013123:0.012508:0.005792:0.006523:0.003848:0.012508:0.007466:0.005330:0.018647:-0.095318
142:@0.896499:0.446502:0.915144:0.446502:0.915144:0.437316:0.896499:0.437316:0.006215:0.006215:0.006215
Lenalidomide is indicated for the treatment :@0.524241:0.467559:0.920515:0.467559:0.920515:0.451803:0.524241:0.451803:0.008678:0.012296:0.011526:0.012931:0.003637:0.003637:0.012969:0.012392:0.017838:0.003637:0.012969:0.012296:0.004253:0.003637:0.007254:0.004253:0.003637:0.011526:0.012969:0.003637:0.012238:0.012931:0.006312:0.012296:0.012969:0.004253:0.005830:0.012392:0.005580:0.004253:0.006312:0.011526:0.012296:0.004253:0.006312:0.005501:0.012296:0.012931:0.006312:0.017838:0.012296:0.011526:0.006521:0.005330
of multiple myeloma, in combination with :@0.524241:0.482997:0.920462:0.482997:0.920462:0.467241:0.524241:0.467241:0.012388:0.005829:0.006240:0.018049:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.006446:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.005330:0.006446:0.003848:0.011738:0.006446:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.006446:0.015990:0.003848:0.006523:0.011738:0.005330
dexamethasone, in patients who have re-:@0.524241:0.498436:0.915154:0.498436:0.915154:0.482680:0.524241:0.482680:0.013181:0.012508:0.009236:0.013143:0.018049:0.012508:0.006523:0.011738:0.013143:0.007466:0.012604:0.011738:0.012508:0.005330:0.005548:0.003848:0.011738:0.005561:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005561:0.015990:0.011738:0.012604:0.005561:0.011738:0.013143:0.010660:0.012508:0.005561:0.005713:0.012508:0.006388
ceived at least one prior therapy. It is also :@0.524241:0.513874:0.920477:0.513874:0.920477:0.498118:0.524241:0.498118:0.012450:0.012508:0.003848:0.010660:0.012508:0.013181:0.005869:0.013143:0.006523:0.005859:0.003848:0.012508:0.013143:0.007466:0.006523:0.005859:0.012604:0.011738:0.012508:0.005850:0.013123:0.005792:0.003848:0.012604:0.005792:0.005854:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005854:0.004349:0.006523:0.005857:0.003848:0.007466:0.005869:0.013143:0.003848:0.007466:0.012604:0.005330
indicated:@0.524241:0.529313:0.614661:0.529313:0.614661:0.513557:0.524241:0.513557:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181
for:@0.646969:0.529313:0.671407:0.529313:0.671407:0.513557:0.646969:0.513557:0.006042:0.012604:0.005792
transfusion-dependent:@0.703715:0.529313:0.915170:0.529313:0.915170:0.513557:0.703715:0.513557:0.006523:0.005792:0.013143:0.011738:0.007466:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.006388:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.012508:0.011738:0.006523
anaemia due to low- or intermediate-1-risk :@0.524241:0.544751:0.920469:0.544751:0.920469:0.528995:0.524241:0.528995:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.004137:0.013181:0.011699:0.012508:0.004137:0.006523:0.012604:0.004137:0.003848:0.012604:0.015990:0.006388:0.004137:0.012604:0.005792:0.004137:0.003848:0.011738:0.006523:0.012508:0.006319:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.006388:0.010660:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330
myelodysplastic  syndromes associated :@0.524241:0.560190:0.920479:0.560190:0.920479:0.544434:0.524241:0.544434:0.018049:0.010314:0.012508:0.003848:0.012604:0.013181:0.010314:0.007466:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.015101:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.007466:0.020416:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330
with a 5q deletion abnormality with or :@0.524241:0.575628:0.920471:0.575628:0.920471:0.559872:0.524241:0.559872:0.015990:0.003848:0.006523:0.011738:0.011661:0.013143:0.011661:0.010660:0.013123:0.011661:0.013181:0.012508:0.003848:0.012508:0.006523:0.003848:0.012604:0.011738:0.011661:0.013143:0.013123:0.011738:0.012604:0.006321:0.018049:0.013143:0.003848:0.003848:0.006523:0.010314:0.011661:0.015990:0.003848:0.006523:0.011738:0.011661:0.012604:0.005792:0.005330
without additional cytogenetic abnormal-:@0.524241:0.591066:0.915129:0.591066:0.915129:0.575311:0.524241:0.575311:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.004714:0.013143:0.013181:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.004714:0.012450:0.010314:0.006523:0.012604:0.012950:0.012508:0.011738:0.012508:0.006523:0.003837:0.012450:0.004714:0.013143:0.013123:0.011738:0.012604:0.006321:0.018049:0.013143:0.003848:0.006388
ities  and mantle-cell  lymphoma patients :@0.524241:0.606505:0.920467:0.606505:0.920467:0.590749:0.524241:0.590749:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.004187:0.013143:0.011738:0.013181:0.009506:0.018049:0.013143:0.011738:0.006523:0.003848:0.012508:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.004189:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.009506:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
whose disease has relapsed or progressed :@0.524241:0.621943:0.920469:0.621943:0.920469:0.606187:0.524241:0.606187:0.015990:0.011738:0.012604:0.007466:0.012508:0.005003:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005015:0.011738:0.013143:0.007466:0.005003:0.005711:0.012508:0.003848:0.013143:0.013123:0.007466:0.012508:0.013181:0.005003:0.012604:0.005792:0.004993:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.012508:0.013181:0.005330
after two prior therapies, one of which in-:@0.524241:0.637382:0.915147:0.637382:0.915147:0.621626:0.524241:0.621626:0.013143:0.006042:0.006523:0.012508:0.005792:0.006485:0.006523:0.015990:0.012604:0.006487:0.013123:0.005792:0.003848:0.012604:0.005792:0.006487:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.005330:0.006489:0.012604:0.011738:0.012498:0.006492:0.012604:0.006042:0.006489:0.015990:0.011738:0.003848:0.012450:0.011738:0.006490:0.003848:0.011738:0.006388
cluded bortezomib.:@0.524241:0.652820:0.708122:0.652820:0.708122:0.637064:0.524241:0.637064:0.012450:0.003848:0.011699:0.013181:0.012508:0.013181:0.005330:0.013123:0.012604:0.005792:0.006523:0.012508:0.008178:0.012604:0.018049:0.003848:0.013123:0.005330
Side effects:@0.524242:0.683072:0.644229:0.683072:0.644229:0.665566:0.524242:0.665566:0.010647:0.004276:0.014646:0.013897:0.005922:0.013897:0.006713:0.006713:0.013897:0.013833:0.007248:0.008296
13:@0.644225:0.676829:0.658036:0.676829:0.658036:0.666623:0.644225:0.666623:0.006905:0.006905
n :@0.524242:0.698592:0.537570:0.698592:0.537570:0.690151:0.524242:0.690151:0.009762:0.003566
 :@0.554542:0.698592:0.558108:0.698592:0.558108:0.690151:0.554542:0.690151:0.003566
Teratogenesis :@0.554545:0.701711:0.686167:0.701711:0.686167:0.685955:0.554545:0.685955:0.007254:0.012508:0.005792:0.013143:0.006523:0.012604:0.012950:0.012508:0.011738:0.012492:0.007466:0.003848:0.007466:0.005330
n :@0.524242:0.714614:0.537570:0.714614:0.537570:0.706173:0.524242:0.706173:0.009762:0.003566
 :@0.554542:0.714614:0.558108:0.714614:0.558108:0.706173:0.554542:0.706173:0.003566
Sedation:@0.554545:0.717733:0.637672:0.717733:0.637672:0.701977:0.554545:0.701977:0.009583:0.012508:0.013181:0.013143:0.006523:0.003848:0.012604:0.011738
n :@0.524242:0.730636:0.537570:0.730636:0.537570:0.722195:0.524242:0.722195:0.009762:0.003566
 :@0.554542:0.730636:0.558108:0.730636:0.558108:0.722195:0.554542:0.722195:0.003566
Constipation :@0.554545:0.733755:0.678678:0.733755:0.678678:0.717999:0.554545:0.717999:0.015644:0.012604:0.011738:0.007466:0.006523:0.003848:0.013123:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
n :@0.524242:0.746658:0.537570:0.746658:0.537570:0.738217:0.524242:0.738217:0.009762:0.003566
 :@0.554542:0.746658:0.558108:0.746658:0.558108:0.738217:0.554542:0.738217:0.003566
Asthenia :@0.554545:0.749777:0.641078:0.749777:0.641078:0.734021:0.554545:0.734021:0.014239:0.007466:0.006523:0.011738:0.012508:0.011738:0.003848:0.013143:0.005330
n :@0.524242:0.762680:0.537570:0.762680:0.537570:0.754239:0.524242:0.754239:0.009762:0.003566
 :@0.554542:0.762680:0.558108:0.762680:0.558108:0.754239:0.554542:0.754239:0.003566
Peripheral neuropathy :@0.554545:0.765799:0.767995:0.765799:0.767995:0.750043:0.554545:0.750043:0.011392:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330:0.011738:0.012508:0.011699:0.005709:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.005330
n :@0.524242:0.778702:0.537570:0.778702:0.537570:0.770261:0.524242:0.770261:0.009762:0.003566
 :@0.554542:0.778702:0.558108:0.778702:0.558108:0.770261:0.554542:0.770261:0.003566
Orthostatic hypotension :@0.554545:0.781821:0.782741:0.781821:0.782741:0.766065:0.554545:0.766065:0.016722:0.005792:0.006523:0.011738:0.012604:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.005330:0.011738:0.010314:0.013123:0.012604:0.006523:0.012508:0.011738:0.007466:0.003848:0.012604:0.011738:0.005330
n :@0.524242:0.794724:0.537570:0.794724:0.537570:0.786283:0.524242:0.786283:0.009762:0.003566
 :@0.554542:0.794724:0.558108:0.794724:0.558108:0.786283:0.554542:0.786283:0.003566
Neutropaenia :@0.554545:0.797843:0.690660:0.797843:0.690660:0.782087:0.554545:0.782087:0.014239:0.012508:0.011699:0.006523:0.005709:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330
n :@0.524242:0.810746:0.537570:0.810746:0.537570:0.802305:0.524242:0.802305:0.009762:0.003566
 :@0.554542:0.810746:0.558108:0.810746:0.558108:0.802305:0.554542:0.802305:0.003566
Severe skin reactions:@0.554545:0.813865:0.747387:0.813865:0.747387:0.798109:0.554545:0.798109:0.009583:0.012508:0.010660:0.012508:0.005711:0.012508:0.005330:0.007466:0.009660:0.003848:0.011738:0.005330:0.005713:0.012508:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466
n :@0.524242:0.826768:0.537570:0.826768:0.537570:0.818327:0.524242:0.818327:0.009762:0.003566
 :@0.554542:0.826768:0.558108:0.826768:0.558108:0.818327:0.554542:0.818327:0.003566
Leukopaenia :@0.554545:0.829887:0.682738:0.829887:0.682738:0.814131:0.554545:0.814131:0.008890:0.012508:0.011699:0.009660:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330
n :@0.524242:0.842790:0.537570:0.842790:0.537570:0.834349:0.524242:0.834349:0.009762:0.003566
 :@0.554542:0.842790:0.558108:0.842790:0.558108:0.834349:0.554542:0.834349:0.003566
Increased appetite   :@0.554545:0.845909:0.760471:0.845909:0.760471:0.830153:0.554545:0.830153:0.004349:0.011738:0.012450:0.005709:0.012508:0.013143:0.007466:0.012508:0.013181:0.005330:0.013143:0.013123:0.013123:0.012508:0.006523:0.003848:0.006523:0.012508:0.005330:0.015586:0.005330
n :@0.524242:0.858812:0.537570:0.858812:0.537570:0.850371:0.524242:0.850371:0.009762:0.003566
 :@0.554542:0.858812:0.558108:0.858812:0.558108:0.850371:0.554542:0.850371:0.003566
Mood changes:@0.554545:0.861931:0.697930:0.861931:0.697930:0.846175:0.554545:0.846175:0.017684:0.012604:0.012594:0.013181:0.005330:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466
n :@0.524242:0.874834:0.537570:0.874834:0.537570:0.866393:0.524242:0.866393:0.009762:0.003566
 :@0.554542:0.874834:0.558108:0.874834:0.558108:0.866393:0.554542:0.866393:0.003566
CNS effects, cardiac arrhythmias :@0.554545:0.877953:0.866237:0.877953:0.866237:0.862197:0.554545:0.862197:0.015644:0.014239:0.009583:0.005330:0.012508:0.006092:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.005330:0.012450:0.013143:0.005675:0.013181:0.003848:0.013143:0.012450:0.005330:0.013143:0.005792:0.006344:0.011738:0.010314:0.006523:0.011738:0.018049:0.003848:0.013143:0.007466:0.005330
n :@0.524242:0.890855:0.537570:0.890855:0.537570:0.882415:0.524242:0.882415:0.009762:0.003566
 :@0.554542:0.890855:0.558108:0.890855:0.558108:0.882415:0.554542:0.882415:0.003566
Bradycardia/tachycardia :@0.554545:0.893975:0.798810:0.893975:0.798810:0.878219:0.554545:0.878219:0.011045:0.005792:0.013143:0.013181:0.010314:0.012450:0.013143:0.005678:0.013181:0.003848:0.013143:0.008409:0.006523:0.013143:0.012450:0.011738:0.010314:0.012450:0.013143:0.005677:0.013181:0.003848:0.013143:0.005330
n :@0.524242:0.906878:0.537570:0.906878:0.537570:0.898437:0.524242:0.898437:0.009762:0.003566
 :@0.554542:0.906878:0.558108:0.906878:0.558108:0.898437:0.554542:0.898437:0.003566
Thrombo-embolisms :@0.554545:0.909997:0.745251:0.909997:0.745251:0.894241:0.554545:0.894241:0.008197:0.011738:0.005709:0.012604:0.018049:0.013123:0.012604:0.006388:0.012508:0.018049:0.013123:0.012604:0.003848:0.003848:0.007466:0.018049:0.007466:0.005330
n :@0.524242:0.922900:0.537570:0.922900:0.537570:0.914459:0.524242:0.914459:0.009762:0.003566
 :@0.554542:0.922900:0.558108:0.922900:0.558108:0.914459:0.554542:0.914459:0.003566
GI disturbances:@0.554545:0.926019:0.699941:0.926019:0.699941:0.910263:0.554545:0.910263:0.016779:0.004349:0.005330:0.013181:0.003848:0.007466:0.006523:0.011699:0.005792:0.013123:0.013143:0.011738:0.012450:0.012508:0.007466
Motor inhibitors, IMiDs:@0.670862:0.038601:0.914560:0.038601:0.914560:0.019343:0.670862:0.019343:0.021613:0.015405:0.007973:0.015405:0.007079:0.006515:0.004704:0.014346:0.014346:0.004704:0.016040:0.004704:0.007973:0.015405:0.007079:0.009125:0.006515:0.006515:0.005315:0.021613:0.004704:0.017498:0.009125